Can a tiny implant track glucose, ketones, and lactate in diabetes?

This trial is testing a new implantable sensor called the HALO System in people with type 1 or type 2 diabetes. The sensor is designed to continuously measure glucose, ketones, and lactate in the fluid just beneath the skin, which could give a more complete picture of metabolic health than glucose alone. The study will check how accurate and stable the sensor readings are over three months, and whether the implantation procedure is safe. If it works, this technology might one day help people with diabetes better manage their condition and avoid dangerous highs and lows.